Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis

European Respiratory Journal

Volumn 11, Issue 2, 1998, Pages 377-383

  Worlitzsch, D ^a   Herberth, G ^a   Ulrich, M ^a   Doring G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

1 Proteinase inhibitor; Catalase; Cystic fibrosis; Hydrogen peroxide; Myeloperoxidase

Indexed keywords

CATALASE; GLYCOCONJUGATE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BRONCHUS MUCOSA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OXYGEN POISONING; PRIORITY JOURNAL; SCHOOL CHILD; SPUTUM;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; BREATH TESTS; CATALASE; CELLS, CULTURED; CHILD; CYSTIC FIBROSIS; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTE ELASTASE; MALE; OXIDANTS; PEROXIDASE; REFERENCE VALUES; RESPIRATION; SPUTUM;

EID: 0031933986     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11020377     Document Type: Article

References (37)

1. Høiby N. Microbiology of lung infections in cystic fibrosis patients. In: Hodson ME, Geddes DM, eds. Cystic Fibrosis. London, Chapman and Hall. 1994: pp. 75-98.
2. Döring G, Knight R, Bellon G. Immunology of cystic fibrosis. In: Hodson ME, Geddes DM, eds. Cystic Fibrosis. London, Chapman and Hall. 1994: pp. 99-129.
3. 1-antitrypsin treatment for cystic fibrosis. Lancet 1991; 337: 392-394.
4. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1: 11-14.
5. Dohlman AW, Black HR, Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993; 148: 955-960.
6. Sznajder JI, Fraiman A, Hall JB, et al. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest 1989; 96: 606-612.
7. Crystal RG. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med 1991; 91 (Suppl. 3C): 39S-45S.
8. Goldstein W, Döring G. Lysosomal enzymes and proteinase inhibitors in the sputum of patients with cystic fibrosis. Am Rev Respir Dis 1986; 134: 49-56.
9. Meyer KC, Zimmerman J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993; 121: 654-661.
10. Regelmann WE, Siefferman CM, Herron JM, Elliott GR, Clawson CC, Gray BH. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr Pulmonol 1995; 19: 1-9.
11. Koller DY, Götz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994; 49: 496-499.
12. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AK. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843-847.
13. Langley SC, Brown RK, Kelly FJ. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993; 33: 247-250.
14. Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993; 75: 2419-2424.
15. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976; 113: 833-878.
16. Hyslop PA, Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem 1974; 141: 280-286.
17. Klebanoff SJ, Waltersdorph AM, Rosen H. Antimicrobial activity of myeloperoxidase. Meth Enzymol 1984; 105: 399-403.
18. Aebi H. Catalase in vitro. Meth Enzymol 1984; 105: 121-126.
19. Bergmeyer HU. Zur Messung von Katalaseaktivitäten. Biochem Z 1955; 327: 255.
20. Döring G, Müller E. Different sensitivity of Pseudomonas aeruginosa exotoxin A and diptheria toxin to enzymes from polymorphonuclear leukocytes. Microbial pathogenesis 1989; 6: 287-295.
21. Jorissen M, van der Schueren B, van den Berghe H, Cassiman J-J. The preservation and regeneration of cilia on human nasal epithelial cells cultured in vivo. Arch Otorhinolaryngol 1989; 246: 303-314.
22. Karnovsky MJ. Cytochemistry and reactive oxygen species: a retrospective. Histochemistry 1994; 102: 15-27.
23. Gallin JI, Leto TL, Rotrosen D, Kwong CH, Malech HL. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. Curr Opin Immunol 1991; 4: 53-56.
24. Weiss SJ. Oxygen, ischemia and inflammation. Acta Physiol Scand 1986; Suppl. 548: 9-37.
25. Cantin A, Woods DE. Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest 1993; 91: 38-45.
26. Pietarinen P, Raivio K, Devlin RB, Crapo JD, Chang L-Y, Kinnula VL. Catalase and glutathione reductase protection of human alveolar macrophages during oxidant exposure in vitro. Am J Respir Cell Mol Biol 1995; 13: 434-441.
27. Yoo JH, Erzurum SC, Hay JG, Lemarchand P, Crystal RG. Vulnerability of the human airway epithelium to hypoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest 1994; 93: 297-302.
28. Dekuijzen PNR, Aben KKH, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 813-816.
29. Mohammed JR, Mohammed BS, Pawluk LJ, Bucci DM, Baker NR, Davis WB. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 1988; 112: 711-720.
30. Brown RK, McBurney A, Lunec J, Kelly FJ. Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med 1995; 18: 801-806.
31. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest 1982; 70: 598-607.
32. Döring G, Goldstein W, Botzenhart K, et al. Elastase from polymorphonuclear leukocytes - a regulatory enzyme in immune complex disease. Clin Exp Immunol 1986; 64: 597-605.
33. Peters SP, Cerasoli F, Jr., Albertine KH, Gee MH, Berd D, Ishihara Y. "Autoregulation" of human neutrophil acitvation in vitro: regulation of phorbol myristate acetate-induced neutrophil activation by cell density. J Leukoc Biol 1990; 47: 457-474.
34. Agner K. Verdoperoxidase. A ferment isolated from leukocytes. Acta Physiol Scand 1958; 2 (Suppl. 8): 1-62.
35. Sommerhoff, CP, Nadel JA, Basbaum CB, Caughey GH. J Clin Invest 1990; 85: 682-689.
36. Picot R, Das I, Reid L. Pus, deoxyribonucleic acid, and sputum viscosity. Thorax 1978; 33: 235-242.
37. Matheson NR, Wong PS, Travis J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun 1979; 88: 402-409.